Entity Public Float of Propanc Biopharma, Inc. from 29 Feb 2012 to 31 Dec 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Propanc Biopharma, Inc. quarterly Entity Public Float in USD history and change rate from 29 Feb 2012 to 31 Dec 2024.
  • Propanc Biopharma, Inc. Entity Public Float for the quarter ending 31 Dec 2024 was $47,895, a 89% decline year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $47,895 -$376,641 -89% 31 Dec 2024 10-K 29 Sep 2025 2025 FY
Q4 2023 $424,536 -$313,915 -43% 29 Dec 2023 10-K 30 Sep 2024 2024 FY
Q4 2022 $738,451 -$781,186 -51% 31 Dec 2022 10-K 28 Sep 2023 2023 FY
Q4 2021 $1,519,637 +$1,192,874 +365% 31 Dec 2021 10-K 28 Sep 2022 2022 FY
Q4 2020 $326,763 -$453,364 -58% 31 Dec 2020 10-K 28 Sep 2021 2021 FY
Q4 2019 $780,127 -$10,505,075 -93% 31 Dec 2019 10-K 01 Oct 2020 2020 FY
Q4 2018 $11,285,202 +$8,855,821 +365% 31 Dec 2018 10-K 15 Oct 2019 2019 FY
Q4 2017 $2,429,381 -$4,414,965 -65% 31 Dec 2017 10-K 17 Sep 2018 2018 FY
Q4 2016 $6,844,346 -$3,242,683 -32% 31 Dec 2016 10-K 28 Sep 2017 2017 FY
Q4 2015 $10,087,029 +$9,921,638 +5999% 31 Dec 2015 10-K 28 Sep 2016 2016 FY
Q4 2014 $165,391 -$5,016,703 -97% 31 Dec 2014 10-K 30 Sep 2015 2015 FY
Q4 2013 $5,182,094 31 Dec 2013 10-K 14 Oct 2014 2014 FY
Q3 2013 $1,797,233 -$10,683,267 -86% 11 Oct 2013 10-K 15 Oct 2013 2013 FY
Q3 2012 $12,480,500 11 Oct 2012 10-K 15 Oct 2012 2012 FY
Q1 2012 $0 29 Feb 2012 10-Q/A 07 Mar 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.